Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.

Carolyn T BramanteKenneth B BeckmanTanvi MehtaAmy B KargerDavid J OddeChristopher J TignanelliJohn B BuseDarrell M JohnsonRay H B WatsonJerry J DanielDavid M LiebovitzJacinda M NicklasKen CohenMichael A PuskarichHrishikesh K BelaniLianne K SiegelNichole R KlattBlake AndersonKatrina M HartmanVia RaoAubrey A HagenBarkha PatelSarah L FennoNandini AvulaNeha V ReddySpencer M EricksonRegina D FrictonSamuel LeeGwendolyn GriffithsMatthew F PullenJennifer L ThompsonNancy E SherwoodThomas A MurrayMichael R RoseDavid R BoulwareJared D Hulingnull null

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

NCT04510194.

Keyphrases

sars cov
double blind
placebo controlled
clinical trial
phase ii
phase iii
study protocol
respiratory syndrome coronavirus
open label
phase ii study
coronavirus disease
randomized controlled trial
squamous cell carcinoma
locally advanced